Journal of the Egyptian National Cancer Institute (JENCI)

Peringkat dan informasi jurnal

Akreditasi Sinta

Tidak berlaku (jurnal luar negeri)

Scopus

Terindeks, kuartil terbaik Q3

SJR 2025

0,551

H-index (SCImago)

33

Cakupan Scopus

2005–2026

ISSN

1110-0362, 2589-0409

Penerbit

Springer Science and Business Media Deutschland GmbH

Negara

Germany

Biaya publikasi (APC)

Gratis (tanpa APC)

DOAJ

Terdaftar di DOAJ (open access)

Kategori dan kuartil Scopus

• OncologyQ3
• Cancer ResearchQ4

Kuartil per kategori dari SCImago Journal Rank 2025. Kuartil terbaik dipakai sebagai peringkat utama.

Cakupan (focus and scope)

All fields of basic, applied and clinical cancer research. Main topics of interest include: local and systemic anticancer therapy (with specific interest on applied cancer research from developing countries); experimental oncology; early cancer detection; randomized trials (including negatives ones); and key emerging fields of personalized medicine, such as molecular pathology, bioinformatics, and biotechnologies.

Pertanyaan umum

Apakah Journal of the Egyptian National Cancer Institute (JENCI) terakreditasi Sinta?

Journal of the Egyptian National Cancer Institute (JENCI) tidak terakreditasi Sinta (Sinta hanya mengakreditasi jurnal Indonesia).

Apakah Journal of the Egyptian National Cancer Institute (JENCI) terindeks Scopus?

Journal of the Egyptian National Cancer Institute (JENCI) terindeks Scopus dengan kuartil terbaik Q3 (SCImago 2025).

Berapa biaya publikasi (APC) di Journal of the Egyptian National Cancer Institute (JENCI)?

Gratis (tanpa APC). Biaya bisa berubah; pastikan di situs jurnal sebelum mengirim naskah.